Pfizer on fast track to getting its vaccine for under-fives approved
Cases among children reached a record high in the US in December, leading to earlier than expected FDA submission
02 February 2022 - 19:38
Pfizer and partner BioNTech say they have started submitting data to US regulators for authorisation of their Covid-19 vaccine for younger children, hastening an effort to get shots to more of them after the Omicron wave caused paediatric infections to jump.
The companies said they have started a rolling submission with the US Food and Drug Administration (FDA) seeking an emergency authorisation for the vaccine in children aged six months to four years. A panel of outside advisers is scheduled to meet on February 15 to consider the request, according to the agency. ..
This article is reserved for Sunday Times subscribers.
A subscription gives you full digital access to all Sunday Times content.
Already subscribed? Simply sign in below.
Registered on the BusinessLIVE, Business Day or Financial Mail websites? Sign in with the same details.
Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.